Literature DB >> 33389161

The impact of total intravenous anesthesia versus inhalation anesthesia on acute kidney injury after major abdominal surgery: a propensity score analysis.

Bo Rim Kim1, Susie Yoon1, Gyu Young Song1, Seohee Lee1, Jae-Hyon Bahk1, Karam Nam2.   

Abstract

PURPOSE: The effect of anesthetic types on postoperative acute kidney injury (AKI) remains unclear particularly in patients undergoing non-cardiac surgery. The purpose of this retrospective study was to compare total intravenous anesthesia (TIVA) and inhalation anesthesia in terms of the risk of AKI after open major abdominal surgery (MAS).
METHODS: Adult patients who underwent open MAS (gastrectomy, hepatectomy, colectomy, or pancreatectomy) at our institute from 2016 to 2018 were included. Using the multivariable logistic regression, the risk of postoperative AKI was compared among patients who underwent TIVA (TIVA group) and inhalation anesthesia (inhalation group) both in the total cohort and in the propensity score-matched cohort. Additional multivariable logistic regression analysis was performed with inverse probability of treatment weighting (IPTW) using the propensity score.
RESULTS: In total, 3616 patients were analyzed. The incidence of postoperative AKI was 5.0% (77/1546) and 7.8% (161/2070) in the TIVA and inhalation groups, respectively. The risk of AKI was significantly higher in the inhalation group [adjusted odds ratio (aOR) 1.72; 95% confidence interval (CI) 1.27-2.35; P = 0.002] than the TIVA group. In the matched cohort (n = 1518 in each group), the inhalation group also had a higher risk of AKI (aOR 1.66; 95% CI 1.20-2.31; P = 0.002). The multivariable logistic regression with IPTW showed similar results (aOR 1.59; 95% CI 1.30-1.95; P < 0.001).
CONCLUSIONS: The risk of AKI after open MAS differed significantly according to the anesthetic used. Patients receiving inhalation anesthesia may have a greater risk of postoperative AKI than those undergoing TIVA.

Entities:  

Keywords:  Acute kidney injury; Anesthetics; Inhalation anesthesia; Total intravenous anesthesia

Mesh:

Substances:

Year:  2021        PMID: 33389161     DOI: 10.1007/s00540-020-02882-9

Source DB:  PubMed          Journal:  J Anesth        ISSN: 0913-8668            Impact factor:   2.078


  4 in total

1.  KDIGO clinical practice guidelines for acute kidney injury.

Authors:  Arif Khwaja
Journal:  Nephron Clin Pract       Date:  2012-08-07

2.  Obesity and oxidative stress predict AKI after cardiac surgery.

Authors:  Frederic T Billings; Mias Pretorius; Jonathan S Schildcrout; Nathaniel D Mercaldo; John G Byrne; T Alp Ikizler; Nancy J Brown
Journal:  J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 10.121

3.  Tissue antioxidant capacity during anesthesia: propofol enhances in vivo red cell and tissue antioxidant capacity in a rat model.

Authors:  Tim D Runzer; David M Ansley; David V Godin; Gordon K Chambers
Journal:  Anesth Analg       Date:  2002-01       Impact factor: 5.108

4.  Acute kidney injury after major abdominal surgery: a retrospective cohort analysis.

Authors:  Catarina Teixeira; Rosário Rosa; Natacha Rodrigues; Inês Mendes; Lígia Peixoto; Sofia Dias; Maria João Melo; Marta Pereira; Henrique Bicha Castelo; José António Lopes
Journal:  Crit Care Res Pract       Date:  2014-02-24
  4 in total
  3 in total

1.  Correlation between perioperative parecoxib use and postoperative acute kidney injury in patients undergoing radical mastectomy: a retrospective cohort analysis.

Authors:  Nan Xu; Ke Pang; Sihua Qi; Hongmei Wang
Journal:  BMC Anesthesiol       Date:  2022-05-20       Impact factor: 2.376

2.  Effects of Anesthetic Technique on the Occurrence of Acute Kidney Injury after Spine Surgery: A Retrospective Cohort Study.

Authors:  Jiwon Han; Ah-Young Oh; Chang-Hoon Koo; Yu Kyung Bae; Yong-Tae Jeon
Journal:  J Clin Med       Date:  2021-11-30       Impact factor: 4.241

3.  Impact of Different KDIGO Criteria on Clinical Outcomes for Early Identification of Acute Kidney Injury after Non-Cardiac Surgery.

Authors:  Jingwen Fu; Junko Kosaka; Hiroshi Morimatsu
Journal:  J Clin Med       Date:  2022-09-23       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.